03:30 PM EST - Response Biomedical Corporation : reported total revenues of $7.6 million in 2010 compared to $9.9 million in 2009 and reduced operating expenses by 13% to $9.2 million in 2010 from $10.6 million in 2009. For the year ended December 31, 2010, the Company recorded a net loss of $9.6 million or $0.31 per share compared to a loss of $9.5 million or $0.43 per share in 2009. Response Biomedical Corporation
shares T.RBM are trading down $0.07 at $0.29.
